LoginRegister
    Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladderStrides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder
    Eisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in IndiaEisai Pharma, Mylan sign agreement commercialize metastatic breast cancer drug TECERIS in India
    Cipla launches skin treatment Daptomycin Injection in USCipla launches skin treatment Daptomycin Injection in US
    CDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by WholesalersCDSCO commitee warns against repacking of Active Pharmaceutical Ingredients into smaller packs by...
    AstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drugAstraZeneca India bags DCGI marketing nod for QTERN-once-daily anti-diabetes drug
    Strides Pharma suspends sale of Ranitidine tab in USStrides Pharma suspends sale of Ranitidine tab in US
    GSK decides to recall antacid Zinetac over safety concernGSK decides to recall antacid Zinetac over safety concern
    Onco.com, dedicated cancer care platform, raises $7 million in Series A fundingOnco.com, dedicated cancer care platform, raises $7 million in Series A funding
    Alembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facilityAlembic JV Aleor Derma gets 1 USFDA observation for Karakhadi facility
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllersCDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug...
    Zydus Cadila: USFDA classifies Ankleshwar facility as No Action IndicatedZydus Cadila: USFDA classifies Ankleshwar facility as No Action Indicated
    Anuh Pharma successfully clears USFDA inspectionAnuh Pharma successfully clears USFDA inspection
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X